Crédit Industriel et Commercial’s Blueprint Medicines BPMC Stock Holding History

Crédit Industriel et Commercial’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-120,850	Closed	-$15.5M	–	362
2025 Q2	$15.5M	Buy	+120,850	New	+$12.6M	1.33%	11

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Crédit Industriel et Commercial's BPMC Position: Q3 2025 in Review

Crédit Industriel et Commercial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 120,850 shares — an estimated $15.5M sold.

Crédit Industriel et Commercial first reported a position in BPMC in Q2 2025 and held it in 1 quarter. The position peaked at $15.5M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Crédit Industriel et Commercial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 120,850 Blueprint Medicines shares in Q3 2025, an estimated $15.5M.
Crédit Industriel et Commercial first reported a position in Blueprint Medicines in Q2 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Blueprint Medicines position peaked at $15.5M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q3 2025, filed 7 Nov 2025.